BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19048618)

  • 1. A novel cell-free screen identifies a potent inhibitor of the Fanconi anemia pathway.
    Landais I; Sobeck A; Stone S; LaChapelle A; Hoatlin ME
    Int J Cancer; 2009 Feb; 124(4):783-92. PubMed ID: 19048618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA structure-induced recruitment and activation of the Fanconi anemia pathway protein FANCD2.
    Sobeck A; Stone S; Hoatlin ME
    Mol Cell Biol; 2007 Jun; 27(12):4283-92. PubMed ID: 17420278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoketone analogs of curcumin, a new class of Fanconi anemia pathway inhibitors.
    Landais I; Hiddingh S; McCarroll M; Yang C; Sun A; Turker MS; Snyder JP; Hoatlin ME
    Mol Cancer; 2009 Dec; 8():133. PubMed ID: 20043851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsenic exposure disrupts the normal function of the FA/BRCA repair pathway.
    Peremartí J; Ramos F; Marcos R; Hernández A
    Toxicol Sci; 2014 Nov; 142(1):93-104. PubMed ID: 25092648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-specific chemical inhibition of the Fanconi anemia pathway sensitizes cancer cells to cisplatin.
    Jacquemont C; Simon JA; D'Andrea AD; Taniguchi T
    Mol Cancer; 2012 Apr; 11():26. PubMed ID: 22537224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The RPA inhibitor HAMNO sensitizes Fanconi anemia pathway-deficient cells.
    Jang SW; Kim JM
    Cell Cycle; 2022 Jul; 21(14):1468-1478. PubMed ID: 35506981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of CHK1 function impedes DNA damage-induced FANCD2 monoubiquitination but normalizes the abnormal G2 arrest in Fanconi anemia.
    Guervilly JH; Macé-Aimé G; Rosselli F
    Hum Mol Genet; 2008 Mar; 17(5):679-89. PubMed ID: 18029388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA interstrand cross-link repair: understanding role of Fanconi anemia pathway and therapeutic implications.
    Shukla P; Solanki A; Ghosh K; Vundinti BR
    Eur J Haematol; 2013 Nov; 91(5):381-93. PubMed ID: 23859405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing over-resection by DNA2 helicase/nuclease suppresses repair defects in Fanconi anemia cells.
    Karanja KK; Lee EH; Hendrickson EA; Campbell JL
    Cell Cycle; 2014; 13(10):1540-50. PubMed ID: 24626199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fanconi anemia proteins are required to prevent accumulation of replication-associated DNA double-strand breaks.
    Sobeck A; Stone S; Costanzo V; de Graaf B; Reuter T; de Winter J; Wallisch M; Akkari Y; Olson S; Wang W; Joenje H; Christian JL; Lupardus PJ; Cimprich KA; Gautier J; Hoatlin ME
    Mol Cell Biol; 2006 Jan; 26(2):425-37. PubMed ID: 16382135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C. elegans: a model of Fanconi anemia and ICL repair.
    Youds JL; Barber LJ; Boulton SJ
    Mutat Res; 2009 Jul; 668(1-2):103-16. PubMed ID: 19059419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Fanconi anemia pathway promotes DNA glycosylase-dependent excision of interstrand DNA crosslinks.
    Macé-Aimé G; Couvé S; Khassenov B; Rosselli F; Saparbaev MK
    Environ Mol Mutagen; 2010 Jul; 51(6):508-19. PubMed ID: 20120016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel role for Fanconi anemia (FA) pathway effector protein FANCD2 in cell cycle progression of untransformed primary human cells.
    Song IY; Barkley LR; Day TA; Weiss RS; Vaziri C
    Cell Cycle; 2010 Jun; 9(12):2375-88. PubMed ID: 20519958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the FA pathway mediated by phosphorylation and ubiquitination.
    Ishiai M; Sato K; Tomida J; Kitao H; Kurumizaka H; Takata M
    Mutat Res; 2017 Oct; 803-805():89-95. PubMed ID: 28552166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FANCD2 binds CtIP and regulates DNA-end resection during DNA interstrand crosslink repair.
    Unno J; Itaya A; Taoka M; Sato K; Tomida J; Sakai W; Sugasawa K; Ishiai M; Ikura T; Isobe T; Kurumizaka H; Takata M
    Cell Rep; 2014 May; 7(4):1039-47. PubMed ID: 24794430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
    Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
    Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cooperation of the NEIL3 and Fanconi anemia/BRCA pathways in interstrand crosslink repair.
    Li N; Wang J; Wallace SS; Chen J; Zhou J; D'Andrea AD
    Nucleic Acids Res; 2020 Apr; 48(6):3014-3028. PubMed ID: 31980815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquisition of Relative Interstrand Crosslinker Resistance and PARP Inhibitor Sensitivity in Fanconi Anemia Head and Neck Cancers.
    Lombardi AJ; Hoskins EE; Foglesong GD; Wikenheiser-Brokamp KA; Wiesmüller L; Hanenberg H; Andreassen PR; Jacobs AJ; Olson SB; Keeble WW; Hays LE; Wells SI
    Clin Cancer Res; 2015 Apr; 21(8):1962-72. PubMed ID: 25609062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitin-like protein UBL5 promotes the functional integrity of the Fanconi anemia pathway.
    Oka Y; Bekker-Jensen S; Mailand N
    EMBO J; 2015 May; 34(10):1385-98. PubMed ID: 25862789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caffeine Has a Synergistic Anticancer Effect with Cisplatin via Inhibiting Fanconi Anemia Group D2 Protein Monoubiquitination in Hepatocellular Carcinoma Cells.
    Oda Y; Hidaka M; Suzuki A
    Biol Pharm Bull; 2017 Nov; 40(11):2005-2009. PubMed ID: 28855448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.